NCT00229385已完成不适用
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 45
- 试验地点
- 1
- 主要终点
- YBOCS
研究概览
简要总结
Comparing schizophrenic patients with comorbid OCD and schizophrenic patients without OCD in response to Ziprasidone and in cognitive functioning as compared with OCD patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of Schizophrenia and OCD for at least 6 months
- •Minimum score of 14 on YBOCS
- •Minimum score of 60 on PANSS
- •Diagnosis of Schizophrenia without OC symptoms
排除标准
- •Patients who are already being treated with ziprasidone
- •Diagnosis of schizophreniform disorder
- •Organic brain syndrome, mental retardation and pervasive developmental disorder
- •Patients having any significantly cardiovascular illness or electrolyte imbalance
研究组 & 干预措施
1
Active Comparator
干预措施: Ziprasidone (Drug)
2
Active Comparator
干预措施: Ziprasidone (Drug)
结局指标
主要结局
YBOCS
时间窗: 8 weeks
次要结局
未报告次要终点
研究者
Prof. Joseph Zohar
Prof. Joseph Zohar
Sheba Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Treatment of Schizophrenic Patients With ZiprasidoneSchizophreniaNCT00579670Pfizer's Upjohn has merged with Mylan to form Viatris Inc.450
已完成
4 期
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for DiabetesMetabolic Syndrome XSchizophreniaInsulin ResistanceNCT00338949Veterans Medical Research Foundation77
已完成
3 期
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsSchizophreniaNCT00649844Pfizer's Upjohn has merged with Mylan to form Viatris Inc.147
已完成
3 期
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic PatientsPsychotic DisordersSchizophreniaSchizoaffective DisorderNCT00159770Pfizer's Upjohn has merged with Mylan to form Viatris Inc.290
进行中（未招募）
不适用
Efficacy and tolerability of Ziprasidone vs. Clozapine in the treatment of dually diagnosed (DD-) patients with schizophrenia and cannabis use disorder: A randomised study - Ziprasidone vs. Clozapine for schizophrenia ans cannabis use disorderPatients with schizophrenia and cannabis abuse/dependency will be randomized to ziprasidone or clozapine treatment. Dose of medication and frequency of administration will be flexible and adjustable depending on clinical requirements. Duration of therapeutic trial:12 monthsEUCTR2005-003156-35-DEDepartment of Psychiatry and Psychotherapy (Cologne)50